11% of Americans Currently Take GLP-1 Weight Loss Drugs Like Wegovy

A new survey shows that 11% of Americans are currently taking GLP-1 weight loss drugs such as Wegovy, while 15% have ever used them — up from 6% in 2024. The figures indicate a sharp rise in the popularity of this class of medication in the United States. The data highlights the growing mainstream adoption of GLP-1 drugs for obesity treatment.